Aaron Larson
Papers
1
Total Citations
13
H-Index
1
About
Aaron Larson is a leading figure in population genomics and precision public health, with a primary focus on translating genetic screening into actionable clinical outcomes. His landmark 2023 study, "Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon," has already garnered 13 citations, underscoring its immediate impact on the field. In this work, Larson demonstrated the feasibility and clinical utility of large-scale, unselected screening for hereditary cancer syndromes and familial hypercholesterolemia, revealing that a significant proportion of the general population carries actionable genetic variants that would otherwise go undetected. This research has profound implications for shifting from reactive, risk-based testing to proactive, population-wide prevention strategies. Larson’s contributions are not merely academic; they provide a blueprint for integrating genomic screening into routine healthcare, potentially saving thousands of lives through early detection and intervention. His work is essential reading for students and researchers interested in the intersection of genomics, public health, and health equity, as it challenges conventional screening paradigms and offers a scalable model for reducing the burden of inherited diseases.
Research Focus
Key Achievements
Top Papers
- 1